(Q36095460)

12 August 2017

1 reference

title

Angiotensin-receptor blockers and diuretics--advantages of combination (English)

1 reference

12 August 2017

Mimran A

1

1 reference

12 August 2017

Weir MR

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

14

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

6-11

1 reference

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Disparate patterns of aldosterone response during diuretic treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

The benefit of treating isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

British Hypertension Society guidelines for hypertension management 1999: summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Characteristics of patients with uncontrolled hypertension in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Adverse prognostic significance of new diabetes in treated hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Racial differences in cardiac structure and function in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Is the blood pressure of people from African origin adults in the UK higher or lower than that in European origin white people? A review of cross-sectional data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050510008832

10.1080/08037050510008832

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference